Annual D&A
$1.53 B
+$4.80 M+0.32%
31 December 2023
Summary:
Eli Lilly and Company annual depreciation & amortization is currently $1.53 billion, with the most recent change of +$4.80 million (+0.32%) on 31 December 2023. During the last 3 years, it has risen by +$203.40 million (+15.36%). LLY annual D&A is now -5.08% below its all-time high of $1.61 billion, reached on 31 December 2018.LLY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$466.80 M
+$52.40 M+12.64%
30 September 2024
Summary:
Eli Lilly and Company quarterly depreciation & amortization is currently $466.80 million, with the most recent change of +$52.40 million (+12.64%) on 30 September 2024. Over the past year, it has increased by +$55.80 million (+13.58%). LLY quarterly D&A is now at all-time high.LLY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.67 B
+$55.80 M+3.46%
30 September 2024
Summary:
Eli Lilly and Company TTM depreciation & amortization is currently $1.67 billion, with the most recent change of +$55.80 million (+3.46%) on 30 September 2024. Over the past year, it has increased by +$154.90 million (+10.23%). LLY TTM D&A is now -0.35% below its all-time high of $1.68 billion, reached on 30 September 2018.LLY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.3% | +13.6% | +10.2% |
| 3 y3 years | +15.4% | +22.1% | +13.6% |
| 5 y5 years | -5.1% | +62.1% | +34.9% |
LLY Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.3% | +15.4% | at high | +33.8% | at high | +15.2% |
| 5 y | 5 years | -5.1% | +23.9% | at high | +70.6% | at high | +45.2% |
| alltime | all time | -5.1% | +566.1% | at high | +515.0% | -0.3% | +1091.7% |
Eli Lilly And Company Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $466.80 M(+12.6%) | $1.67 B(+3.5%) |
| June 2024 | - | $414.40 M(+3.4%) | $1.61 B(+3.1%) |
| Mar 2024 | - | $400.60 M(+3.3%) | $1.57 B(+2.5%) |
| Dec 2023 | $1.53 B(+0.3%) | $387.70 M(-5.7%) | $1.53 B(+0.8%) |
| Sept 2023 | - | $411.00 M(+12.2%) | $1.51 B(+3.3%) |
| June 2023 | - | $366.30 M(+1.1%) | $1.47 B(+1.2%) |
| Mar 2023 | - | $362.30 M(-3.4%) | $1.45 B(-4.8%) |
| Dec 2022 | $1.52 B(-1.6%) | $375.00 M(+3.3%) | $1.52 B(-4.4%) |
| Sept 2022 | - | $362.90 M(+4.0%) | $1.59 B(-1.2%) |
| June 2022 | - | $348.90 M(-19.9%) | $1.61 B(-1.2%) |
| Mar 2022 | - | $435.70 M(-2.2%) | $1.63 B(+5.5%) |
| Dec 2021 | $1.55 B(+16.9%) | $445.70 M(+16.6%) | $1.55 B(+5.3%) |
| Sept 2021 | - | $382.30 M(+3.5%) | $1.47 B(+1.7%) |
| June 2021 | - | $369.30 M(+5.4%) | $1.45 B(+3.2%) |
| Mar 2021 | - | $350.30 M(-4.7%) | $1.40 B(+5.8%) |
| Dec 2020 | $1.32 B(+7.4%) | $367.50 M(+2.5%) | $1.32 B(+2.1%) |
| Sept 2020 | - | $358.40 M(+10.5%) | $1.30 B(+5.7%) |
| June 2020 | - | $324.40 M(+18.6%) | $1.23 B(+6.7%) |
| Mar 2020 | - | $273.60 M(-19.7%) | $1.15 B(-6.7%) |
| Dec 2019 | $1.23 B(-23.4%) | $340.70 M(+18.3%) | $1.23 B(-0.4%) |
| Sept 2019 | - | $288.00 M(+16.4%) | $1.24 B(-9.3%) |
| June 2019 | - | $247.40 M(-30.6%) | $1.36 B(-11.5%) |
| Mar 2019 | - | $356.50 M(+3.2%) | $1.54 B(-4.1%) |
| Dec 2018 | $1.61 B(+2.7%) | $345.50 M(-16.8%) | $1.61 B(-4.0%) |
| Sept 2018 | - | $415.50 M(-2.3%) | $1.68 B(+2.6%) |
| June 2018 | - | $425.20 M(+0.6%) | $1.63 B(+1.8%) |
| Mar 2018 | - | $422.80 M(+2.6%) | $1.60 B(+2.3%) |
| Dec 2017 | $1.57 B(+4.7%) | $411.90 M(+10.5%) | $1.57 B(+4.5%) |
| Sept 2017 | - | $372.90 M(-5.7%) | $1.50 B(-1.3%) |
| June 2017 | - | $395.60 M(+2.2%) | $1.52 B(+1.5%) |
| Mar 2017 | - | $386.90 M(+12.3%) | $1.50 B(+0.1%) |
| Dec 2016 | $1.50 B(+4.8%) | $344.60 M(-12.3%) | $1.50 B(+0.1%) |
| Sept 2016 | - | $392.80 M(+5.1%) | $1.50 B(+2.4%) |
| June 2016 | - | $373.70 M(-3.1%) | $1.46 B(+0.4%) |
| Mar 2016 | - | $385.50 M(+12.3%) | $1.46 B(+2.0%) |
| Dec 2015 | $1.43 B(+3.5%) | $343.40 M(-4.2%) | $1.43 B(+0.3%) |
| Sept 2015 | - | $358.30 M(-2.8%) | $1.42 B(+1.1%) |
| June 2015 | - | $368.50 M(+3.1%) | $1.41 B(+1.4%) |
| Mar 2015 | - | $357.50 M(+5.3%) | $1.39 B(+0.6%) |
| Dec 2014 | $1.38 B(-4.6%) | $339.40 M(-0.9%) | $1.38 B(-0.8%) |
| Sept 2014 | - | $342.40 M(-1.7%) | $1.39 B(-0.5%) |
| June 2014 | - | $348.40 M(-0.1%) | $1.40 B(-1.1%) |
| Mar 2014 | - | $348.80 M(-0.7%) | $1.41 B(-2.3%) |
| Dec 2013 | $1.45 B(-1.1%) | $351.20 M(+0.6%) | $1.45 B(+0.5%) |
| Sept 2013 | - | $349.00 M(-4.1%) | $1.44 B(-1.4%) |
| June 2013 | - | $363.90 M(-4.6%) | $1.46 B(+0.1%) |
| Mar 2013 | - | $381.50 M(+10.7%) | $1.46 B(-0.3%) |
| Dec 2012 | $1.46 B(+6.5%) | $344.60 M(-6.8%) | $1.46 B(+1.8%) |
| Sept 2012 | - | $369.70 M(+2.1%) | $1.44 B(+0.8%) |
| June 2012 | - | $362.00 M(-6.2%) | $1.43 B(+0.5%) |
| Mar 2012 | - | $385.90 M(+21.0%) | $1.42 B(+3.3%) |
| Dec 2011 | $1.37 B(+3.4%) | $318.90 M(-11.0%) | $1.37 B(-1.4%) |
| Sept 2011 | - | $358.20 M(+0.7%) | $1.39 B(+1.0%) |
| June 2011 | - | $355.60 M(+4.3%) | $1.38 B(+0.7%) |
| Mar 2011 | - | $340.90 M(+0.7%) | $1.37 B(+3.1%) |
| Dec 2010 | $1.33 B(+2.3%) | $338.50 M(-1.8%) | $1.33 B(-2.7%) |
| Sept 2010 | - | $344.70 M(-0.3%) | $1.37 B(+2.6%) |
| June 2010 | - | $345.60 M(+15.4%) | $1.33 B(+3.1%) |
| Mar 2010 | - | $299.40 M(-20.3%) | $1.29 B(-0.5%) |
| Dec 2009 | $1.30 B | $375.80 M(+21.3%) | $1.30 B(+7.9%) |
| Sept 2009 | - | $309.70 M(+1.2%) | $1.20 B(+2.2%) |
| June 2009 | - | $306.00 M(-0.1%) | $1.18 B(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $306.30 M(+9.3%) | $1.15 B(+2.6%) |
| Dec 2008 | $1.12 B(+7.1%) | $280.30 M(-1.1%) | $1.12 B(+0.5%) |
| Sept 2008 | - | $283.30 M(+0.6%) | $1.12 B(+1.6%) |
| June 2008 | - | $281.50 M(+1.4%) | $1.10 B(+1.8%) |
| Mar 2008 | - | $277.50 M(+1.0%) | $1.08 B(+3.1%) |
| Dec 2007 | $1.05 B(+30.7%) | $274.80 M(+3.5%) | $1.05 B(+10.7%) |
| Sept 2007 | - | $265.50 M(+1.1%) | $946.70 M(+5.7%) |
| June 2007 | - | $262.50 M(+7.1%) | $895.40 M(+6.3%) |
| Mar 2007 | - | $245.10 M(+41.2%) | $842.00 M(+5.0%) |
| Dec 2006 | $801.80 M(+10.4%) | $173.60 M(-19.0%) | $801.80 M(-6.0%) |
| Sept 2006 | - | $214.20 M(+2.4%) | $853.30 M(+3.7%) |
| June 2006 | - | $209.10 M(+2.0%) | $823.00 M(+6.5%) |
| Mar 2006 | - | $204.90 M(-9.0%) | $772.60 M(+6.4%) |
| Dec 2005 | $726.40 M(+21.6%) | $225.10 M(+22.4%) | $726.40 M(+13.9%) |
| Sept 2005 | - | $183.90 M(+15.9%) | $638.00 M(+3.4%) |
| June 2005 | - | $158.70 M(0.0%) | $617.30 M(+1.4%) |
| Mar 2005 | - | $158.70 M(+16.1%) | $608.60 M(+1.9%) |
| Dec 2004 | $597.50 M(+8.9%) | $136.70 M(-16.2%) | $597.50 M(+5.3%) |
| Sept 2004 | - | $163.20 M(+8.8%) | $567.40 M(+1.8%) |
| June 2004 | - | $150.00 M(+1.6%) | $557.50 M(+1.1%) |
| Mar 2004 | - | $147.60 M(+38.5%) | $551.50 M(+0.5%) |
| Dec 2003 | $548.50 M(+11.3%) | $106.60 M(-30.5%) | $548.50 M(+1.3%) |
| Sept 2003 | - | $153.30 M(+6.5%) | $541.60 M(+4.4%) |
| June 2003 | - | $144.00 M(-0.4%) | $518.90 M(+2.5%) |
| Mar 2003 | - | $144.60 M(+45.0%) | $506.20 M(+2.7%) |
| Dec 2002 | $493.00 M(+8.4%) | $99.70 M(-23.7%) | $493.00 M(+4.7%) |
| Sept 2002 | - | $130.60 M(-0.5%) | $470.90 M(+0.2%) |
| June 2002 | - | $131.30 M(-0.1%) | $469.80 M(+0.8%) |
| Mar 2002 | - | $131.40 M(+69.3%) | $465.90 M(+2.4%) |
| Dec 2001 | $454.90 M(+4.4%) | $77.60 M(-40.1%) | $454.90 M(+0.4%) |
| Sept 2001 | - | $129.50 M(+1.6%) | $453.20 M(+1.6%) |
| June 2001 | - | $127.40 M(+5.8%) | $446.20 M(+1.4%) |
| Mar 2001 | - | $120.40 M(+58.6%) | $440.00 M(+1.0%) |
| Dec 2000 | $435.80 M(-0.9%) | $75.90 M(-38.0%) | $435.80 M(-5.1%) |
| Sept 2000 | - | $122.50 M(+1.1%) | $459.20 M(+1.4%) |
| June 2000 | - | $121.20 M(+4.3%) | $452.70 M(+2.1%) |
| Mar 2000 | - | $116.20 M(+17.0%) | $443.50 M(+0.9%) |
| Dec 1999 | $439.70 M(-10.3%) | $99.30 M(-14.4%) | $439.70 M(-6.8%) |
| Sept 1999 | - | $116.00 M(+3.6%) | $472.00 M(-1.3%) |
| June 1999 | - | $112.00 M(-0.4%) | $478.40 M(-1.1%) |
| Mar 1999 | - | $112.40 M(-14.6%) | $483.60 M(-1.4%) |
| Dec 1998 | $490.40 M(-3.8%) | $131.60 M(+7.5%) | $490.40 M(+4.6%) |
| Sept 1998 | - | $122.40 M(+4.4%) | $468.80 M(-0.5%) |
| June 1998 | - | $117.20 M(-1.7%) | $471.20 M(-3.8%) |
| Mar 1998 | - | $119.20 M(+8.4%) | $490.00 M(-3.9%) |
| Dec 1997 | $509.80 M(-6.2%) | $110.00 M(-11.9%) | $509.80 M(-5.3%) |
| Sept 1997 | - | $124.80 M(-8.2%) | $538.50 M(-2.0%) |
| June 1997 | - | $136.00 M(-2.2%) | $549.60 M(-0.0%) |
| Mar 1997 | - | $139.00 M(+0.2%) | $549.80 M(+1.2%) |
| Dec 1996 | $543.50 M(-1.8%) | $138.70 M(+2.1%) | $543.50 M(+0.9%) |
| Sept 1996 | - | $135.90 M(-0.2%) | $538.70 M(-0.8%) |
| June 1996 | - | $136.20 M(+2.6%) | $543.30 M(-0.5%) |
| Mar 1996 | - | $132.70 M(-0.9%) | $546.30 M(-1.3%) |
| Dec 1995 | $553.70 M(+28.1%) | $133.90 M(-4.7%) | $553.70 M(+31.9%) |
| Sept 1995 | - | $140.50 M(+0.9%) | $419.80 M(+50.3%) |
| June 1995 | - | $139.20 M(-0.6%) | $279.30 M(+99.4%) |
| Mar 1995 | - | $140.10 M | $140.10 M |
| Dec 1994 | $432.20 M(+8.5%) | - | - |
| Dec 1993 | $398.30 M(+8.2%) | - | - |
| Dec 1992 | $368.10 M(+22.9%) | - | - |
| Dec 1991 | $299.50 M(+21.0%) | - | - |
| Dec 1990 | $247.50 M(+7.9%) | - | - |
| Dec 1989 | $229.30 M | - | - |
FAQ
- What is Eli Lilly and Company annual depreciation & amortization?
- What is the all time high annual D&A for Eli Lilly and Company?
- What is Eli Lilly and Company annual D&A year-on-year change?
- What is Eli Lilly and Company quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly D&A year-on-year change?
- What is Eli Lilly and Company TTM depreciation & amortization?
- What is the all time high TTM D&A for Eli Lilly and Company?
- What is Eli Lilly and Company TTM D&A year-on-year change?
What is Eli Lilly and Company annual depreciation & amortization?
The current annual D&A of LLY is $1.53 B
What is the all time high annual D&A for Eli Lilly and Company?
Eli Lilly and Company all-time high annual depreciation & amortization is $1.61 B
What is Eli Lilly and Company annual D&A year-on-year change?
Over the past year, LLY annual depreciation & amortization has changed by +$4.80 M (+0.32%)
What is Eli Lilly and Company quarterly depreciation & amortization?
The current quarterly D&A of LLY is $466.80 M
What is the all time high quarterly D&A for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly depreciation & amortization is $466.80 M
What is Eli Lilly and Company quarterly D&A year-on-year change?
Over the past year, LLY quarterly depreciation & amortization has changed by +$55.80 M (+13.58%)
What is Eli Lilly and Company TTM depreciation & amortization?
The current TTM D&A of LLY is $1.67 B
What is the all time high TTM D&A for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM depreciation & amortization is $1.68 B
What is Eli Lilly and Company TTM D&A year-on-year change?
Over the past year, LLY TTM depreciation & amortization has changed by +$154.90 M (+10.23%)